A study to compare effect of intravaginal application of Nimbadi cream and Capsule Clingen forte in vaginal infectio
Phase 2
- Conditions
- Health Condition 1: N761- Subacute and chronic vaginitis
- Registration Number
- CTRI/2023/09/057505
- Lead Sponsor
- Dr Deepika Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with complaints of white discharge per vagina
2. Itching and pain in vulva and vagina.
3. They had not used antibiotics, immunosuppressive drugs, or vaginal drugs 14 days before the study.
4. Those patients who are ready to sign informed consent form.
Exclusion Criteria
1. Pregnant women
2. Patients suffering from systemic diseases like hypertension, tuberculosis, diabetes mellitus
3. Positive test for Syphilis or HIV
4. Patient having history of any drug allergy.
5. Pathology of reproductive system (genital malignancy, tubo-ovarian abscess, bartholin abscess, erosion of cervix, cervical polyp, acute pelvic inflammatory disease, second and third degree uterine prolapse, genital dermatological conditions, etc.)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of sign and symptoms of vulvovaginitis based on subjective parameters like amount of vaginal discharge, vaginal discharge consistency, odour of vaginal discharge, itching in external genitalia, vulval and vaginal pain and Objective parameters like vaginal pH, whiff test, wet vaginal smearTimepoint: Day 0, Day 15, Day 30, Day 45
- Secondary Outcome Measures
Name Time Method RecurrenceTimepoint: Day 45